Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease
Javier Castillo‐Olivares, David A. Wells, Matteo Ferrari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19

Showing 19 citing articles:

SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 282
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
Diego Cantoni, Craig Wilkie, Emma M. Bentley, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin—Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases
Jason K. Iles, Raminta Zmuidinaite, Christoph Sadée, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4126-4126
Open Access | Times Cited: 20
Quantifying the role of naturally- and vaccine-derived neutralizing antibodies as a correlate of protection against COVID-19 variants
Jamie A. Cohen, Robyn M. Stuart, Katherine Rosenfeld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 27
Proteases and variants: context matters for SARS-CoV-2 entry assays
Christian S. Stevens, Kasopefoluwa Y. Oguntuyo, Benhur Lee
Current Opinion in Virology (2021) Vol. 50, pp. 49-58
Open Access | Times Cited: 26
Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
Kristin Greve-Isdahl Mohn, Geir Bredholt, Fan Zhou, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0261979-e0261979
Open Access | Times Cited: 13
Direct Detection of Glycated Human Serum Albumin and Hyperglycosylated IgG3 in Serum, by MALDI-ToF Mass Spectrometry, as a Predictor of COVID-19 Severity
Ray K. Iles, Jason K. Iles, Jonathan Lacey, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2521-2521
Open Access | Times Cited: 12
Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation
Sebastian Einhauser, David Peterhoff, Hans Helmut Niller, et al.
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1843-1843
Open Access | Times Cited: 16
Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
Jason K. Iles, Raminta Zmuidinaite, Christoph Sadée, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6050-6050
Open Access | Times Cited: 11
Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study
Ana Atti, Matteo Ferrari, Javier Castillo‐Olivares, et al.
Journal of Infection (2021) Vol. 84, Iss. 2, pp. 248-288
Open Access | Times Cited: 6
SARS-CoV-2 and HIV-1: Should HIV-1-Infected Individuals in Sub-Saharan Africa Be Considered a Priority Group for the COVID-19 Vaccines?
Wilson L. Mandala, Michael K. P. Liu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 6
The changing impact of vaccines in the COVID-19 pandemic
Jamie A. Cohen, Robyn M. Stuart, Jasmina Panovska‐Griffiths, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest
Ray K. Iles
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
SARS-CoV-2 Spike protein binding of glycated serum albumin - its potential role in the pathogenesis of the COVID-19 clinical syndromes and bias towards individuals with pre-diabetes/type 2 diabetes & metabolic diseases
Jason K IIes, Raminta Zmuidinaite, Christoph Sadée, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Determination of IgG1 and IgG3 SARS-CoV-2 spike protein and nucleocapsid binding – Who is binding who and why?
Jason K IIes, Raminta Zmuidinaite, Christoph Sadée, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Neutralisation hierarchy of SARS-CoV-2 Variants of Concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholds
Diego Cantoni, Martin Mayora‐Neto, Angalee Nadesalingham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected Patients
Diego Cantoni, Martin Mayora‐Neto, Nazia Thakur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Direct detection of humoral marker corelates of COVID-19, glycated HSA and hyperglycosylated IgG3, by MALDI-ToF mass spectrometry
Ray K. Iles, Jason K IIes, Raminta Zmuidinaite, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Endemic Seasonal Coronavirus Neutralisation and COVID-19 severity
David A. Wells, Diego Cantoni, Martin Mayora‐Neto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top